 Management Announcement
August 1, 2024
Sunrun s Net-Zero and Emissions Reductions Targets Approved by Science Based Targets Initiative
SAN FRANCISCO, Aug. 01, 2024 - Sunrun (Nasdaq: RUN), the nation s leading provider of clean energy as a subscription service, announced today that its near and long-term greenhouse gas emissions reduction targets...
|
Product Service News
August 1, 2024
Expansion Amidst Challenges: FreightCar America, Inc. Ventures into Tank Cars with Multi-Year OrderFreightCar America, Inc. (NASDAQ: RAIL), a distinguished name in railcar manufacturing with a storied legacy spanning over 120 years, has announced a pivotal expansion into tank car conversions, secured by a significa...
|
Clinical Study
August 1, 2024
: The integration of non-invasive vagus nerve stimulation (nVNS) into educational environments presents an innovative approach to enhancing cognitive functions, particularly in language acquisition. Recent clinical trials suggest that nVNS may significantly accelerate foreign language learning while concurrently imp...
|
|
 Product Service News
August 1, 2024
Enphase Energy Expands Deployment of IQ8 Microinverters in Europe Amidst Challenging Market Conditions Fremont, Calif., Aug. 01, 2024 Enphase Energy, Inc.(https://www.globenewswire.com/Tracker data=fWq0oTT8zPR6bkIHX-QWg_I6m6yB2QKcpJ1CHaM489BRoqXM2ZJDEixGTO52dV0jChldUb-L9EqVeIfOB9B1xC4Mn5hbhFLB-we6XmyKPak=) (NASDAQ:...
 Clinical Study
August 1, 2024
Adverum Biotechnologies Secures FDA RMAT Designation for Ixo-vec, Showcasing Promising Efficacy in Wet AMD Treatment In a significant development within the biotechnology sector, Adverum Biotechnologies, Inc. (Nasdaq: ADVM), has announced that the U.S. Food and Drug Administration (FDA) has conferred Regenerative Me...
|
|
Our most Popular Articles
|
Business Update
October 9, 2024
In an era where precision, speed, and technological integration define success in financial services, Open Lending Corporation (NASDAQ: LPRO) has firmly established itself as a vanguard in automotive lending enablement and risk analytics solutions. Originating from its roots in Austin, Texas, the company recently an...
|
Business Update
November 10, 2024
As the insurance industry navigates the complexities of digital transformation, cloud adoption emerges as a pivotal strategy for Property and Casualty (P&C) insurance carriers to maintain competitive edge and operational efficiency. OneSpan Inc. a leader in digital identity and anti-fraud solutions, has taken a sign...
|
Product Service News
July 18, 2024
LPL Financial Welcomes Prestigious Advisors to Its Growing NetworkSAN DIEGO In a testament to its reputation and robust platform, LPL Financial LLC has recently welcomed several distinguished financial advisors and their teams to its prestigious network. Each group brings a wealth of experience and a substantial por...
|
|
|
Company News
|
Product Service News
August 1, 2024
Expansion Amidst Challenges: FreightCar America, Inc. Ventures into Tank Cars with Multi-Year OrderFreightCar America, Inc. (NASDAQ: RAIL), a distinguished name in railcar manufacturing with a storied legacy spanning over 120 years, has announced a pivotal expansion into tank car conversions, secured by a significa...
|
Clinical Study
August 1, 2024
: The integration of non-invasive vagus nerve stimulation (nVNS) into educational environments presents an innovative approach to enhancing cognitive functions, particularly in language acquisition. Recent clinical trials suggest that nVNS may significantly accelerate foreign language learning while concurrently imp...
|
Announcement
August 1, 2024
Equity Awards Granted to New Employees at Abeona Therapeutics Under Nasdaq Listing Rule 5635(c)(4) CSIMarket.com Abeona Therapeutics Inc. (Nasdaq: ABEO), a pioneering company in the realm of gene and cell therapy, has announced the implementation of equity awards for newly onboarded non-executive employees. Thi...
|
|
|
Company News
 Clinical Study
August 1, 2024
|
Company News
 Management Announcement
August 1, 2024
|
Company News
 Partnership
August 1, 2024
|
More Company News
|
Financing Agreement
August 1, 2024
|
Announcement
August 1, 2024
|
Announcement
August 1, 2024
|
Business Update
August 1, 2024
|
Announcement
August 1, 2024
|
Clinical Study
August 1, 2024
|
Licensing Agreement
August 1, 2024
|
Product Service News
August 1, 2024
|
Product Service News
August 1, 2024
|
Management Announcement
August 1, 2024
|
|
|
|
Related News
|
Management Announcement
|
Licensing Agreement
|
|
Stocks
|
Product Service News
|
Business Update
|
Business Update
|
|
|
|
Business News
|
 Product Service News
Enphase Energy Expands Deployment of IQ8 Microinverters in Europe Amidst Challenging Market Conditions Fremont, Calif., Aug. 01, 2024 Enphase Energy, Inc.(https://www.globenewswire.com/Tracker data=fWq0oTT8zPR6bkIHX-QWg_I6m6yB2QKcpJ1CHaM489BRoqXM2ZJDEixGTO52dV0jChldUb-L9EqVeIfOB9B1xC4Mn5hbhFLB-we6XmyKPak=) (NASDAQ:...
|
|
Clinical Study
Adverum Biotechnologies Secures FDA RMAT Designation for Ixo-vec, Showcasing Promising Efficacy in Wet AMD Treatment In a significant development within the biotechnology sector, Adverum Biotechnologies, Inc. (Nasdaq: ADVM), has announced that the U.S. Food and Drug Administration (FDA) has conferred Regenerative Me...
|
 Clinical Study
Bionano Genomics, Inc. has announced its participation in the Cancer Genomics Consortium (CGC) 2024 Annual Meeting, showcasing the utility of optical genome mapping (OGM) in cancer research. This article reviews the significance of OGM, the content presented at the meeting, and its implications for the study of h...
|
 Financing Agreement
Sunrise Realty Trust, Inc. (SUNS), a prominent real estate investment firm, recently announced its significant commitment of $27.3 million in a senior loan for the refinancing of the luxurious Thompson San Antonio Hotel. This financing arrangement, the second completed between SUNS and renowned real estate...
|
 Management Announcement
Sunrun s Net-Zero and Emissions Reductions Targets Approved by Science Based Targets Initiative
SAN FRANCISCO, Aug. 01, 2024 - Sunrun (Nasdaq: RUN), the nation s leading provider of clean energy as a subscription service, announced today that its near and long-term greenhouse gas emissions reduction targets...
|
Our Most Popular Articles
|
 Business Update
In an era where precision, speed, and technological integration define success in financial services, Open Lending Corporation (NASDAQ: LPRO) has firmly established itself as a vanguard in automotive lending enablement and risk analytics solutions. Originating from its roots in Austin, Texas, the company recently an...
|
 Business Update
As the insurance industry navigates the complexities of digital transformation, cloud adoption emerges as a pivotal strategy for Property and Casualty (P&C) insurance carriers to maintain competitive edge and operational efficiency. OneSpan Inc. a leader in digital identity and anti-fraud solutions, has taken a sign...
|
 Product Service News
LPL Financial Welcomes Prestigious Advisors to Its Growing NetworkSAN DIEGO In a testament to its reputation and robust platform, LPL Financial LLC has recently welcomed several distinguished financial advisors and their teams to its prestigious network. Each group brings a wealth of experience and a substantial por...
|
More News
|
 Product Service News
Expansion Amidst Challenges: FreightCar America, Inc. Ventures into Tank Cars with Multi-Year OrderFreightCar America, Inc. (NASDAQ: RAIL), a distinguished name in railcar manufacturing with a storied legacy spanning over 120 years, has announced a pivotal expansion into tank car conversions, secured by a significa...
|
 Clinical Study
: The integration of non-invasive vagus nerve stimulation (nVNS) into educational environments presents an innovative approach to enhancing cognitive functions, particularly in language acquisition. Recent clinical trials suggest that nVNS may significantly accelerate foreign language learning while concurrently imp...
|
 Announcement
Equity Awards Granted to New Employees at Abeona Therapeutics Under Nasdaq Listing Rule 5635(c)(4) CSIMarket.com Abeona Therapeutics Inc. (Nasdaq: ABEO), a pioneering company in the realm of gene and cell therapy, has announced the implementation of equity awards for newly onboarded non-executive employees. Thi...
|
 Clinical Study
Context Therapeutics Inc., a pioneering company in the development of novel cancer therapies, has made a significant formal announcement regarding its leadership and clinical strategy. The recent appointments of Dr. Claudio Dansky Ullmann as Chief Medical Officer (CMO) and Ms. Karen Andreas as Vice President (VP) of...
|
 Management Announcement
Capital City Bank Climbs to 19th Among the Best Companies to Work For in Florida
TALLAHASSEE, Fla., Aug. 01, 2024 - Capital City Bank has once again been recognized as one of the best companies to work for in Florida. The bank secured the 19th position in the Large Companies category in Florida Trends annual li...
|
 Partnership
In a significant development poised to advance the capabilities of artificial intelligence (AI) networks, POET Technologies Inc. (POET or the Company) and Luxshare Technology Co. Ltd. (Luxshare Tech) have announced that they are expanding their partnership. This collaboration aims to introduce a series of enhanced o...
|
 Financing Agreement
Passage Bio Partners with GEMMA Biotherapeutics to Advance Pediatric Gene Therapy Programs
Imagine a world where devastating genetic diseases that afflict children have effective treatments. Thanks to groundbreaking research and collaboration, that world might not be too far away. Passage Bio, a leading genetic ...
|
 Announcement
Advancements in Neurodegenerative Therapeutics: ProMIS Neurosciences Progress and Upcoming Milestones Neurodegenerative diseases such as Alzheimer s disease represent significant challenges in modern medicine, with high rates of morbidity and mortality. Advancements in biotechnology have facilitated the exploratio...
|
 Announcement
Ferrari N.V. Q2 2024 Results Confirm Strong Execution and Continued Growth; 2024 Guidance Revised UpwardFerrari N.V. (NYSE/EXM: RACE), a name synonymous with luxury and performance in the automotive world, has released its consolidated preliminary results for the second quarter and the first six months ended June 3...
|
 Business Update
8x8 Revolutionizes Housing Maintenance with AI-Powered Solution LONDON In a groundbreaking advancement, 8x8, Inc. (NASDAQ: EGHT), a leader in integrated cloud communications and customer engagement solutions, has unveiled 8x8 Active Assessor: an innovative AI-powered solution aimed explicitly at reducing the costs...
|
 Announcement
In a significant development for the world of sports and journalism, Gray Media is poised to enhance the entertainment landscape across the nation. The media conglomerate recently announced two pivotal initiatives: the launch of statewide broadcasts featuring Palmetto Sports & Entertainment and the historic live air...
|
 Clinical Study
In recent developments concerning hemolytic anemias, Agios Pharmaceuticals has reported compelling results from multiple Phase 3 clinical studies investigating the therapeutic potential of Mitapivat. This article reviews the findings from the ACTIVATE-KidsT study, focusing on children experiencing pyruvate kinase...
|
 Licensing Agreement
In an industry-defining collaboration, Instil Bio, Inc. (Nasdaq: TIL, Instil) and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKEX Code: 1541.HK, ImmuneOnco) have announced a landmark agreement focusing on innovative immunotherapy solutions. The pivotal development saw Instil obtaining exclusive ex-China development and commercial rights to ImmuneOnco’s pioneering PD-L1xVEGF bispecific antibody, IMM2510, along with a next-generation anti-CTLA-4 antibody, IMM27M.This collaboration positions both companies at the forefront of immunotherapy advancements, targeting complex mechanisms in the tumor microenvironment to bolster anti-cancer efficacy. The focus on PD-L1xVEGF and anti-CTLA-4 antibodies aims to expedite the development of novel therapies to address various forms of cancer, potentially transforming patient outcomes worldwide.
|
 Product Service News
In a significant development aimed at bolstering its data management capabilities, EXL has acquired ITI Data, a move that is expected to accelerate the company’s data and AI-led strategy across various sectors, particularly in banking and healthcare. This strategic acquisition not only enhances EXL s technological...
|
 Product Service News
NIO Inc.: Navigating Challenges in the Premium Electric Vehicle Market In the fast-evolving landscape of electric vehicles (EVs), NIO Inc., a leading player in the premium smart electric vehicle market, faces the dual challenge of maintaining growth while adapting to shifting market conditions. Significant developme...
|
 Management Announcement
By , CSI Market Correspondent
Published
GUANGZHOU, China - XPeng Inc. (NYSE: XPEV and HKEX: 9868), a prominent Chinese smart electric vehicle (Smart EV) company, released its vehicle delivery results for July 2024 amidst a challenging fiscal year. The company s negative return on investment (ROI) of -2...
|
|
|
|
|
